| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500642 | Farmacia Hospitalaria | 2006 | 5 Pages |
Abstract
In our experience, imatinib is an effective, well tolerated therapy for malignant [c-Kit (CD117)-positive], nonresectable and/or metastatic GIST.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
J. Giménez Castellanos, E. Sánchez Gómez, J.J. Reina Zoiló, E. Gabella Bazarot, I. MarÃn Ariza, S. Grutzmancher Saiz,